CMPS Earnings

CMPS reported its FY2025Q3 earnings on 2025-11-04, showcasing a revenue of 0.00 against an estimate of , resulting in a 0% surprise. The EPS was -0.38, surpassing the expected -0.4 by 5%. The stock experienced a 11.43% price change on the earnings day and a -8.4% change over the next five days, reflecting market reactions to the results.

Following CMPS's FY2025Q3 earnings announcement on 2025-11-04, the stock price moved by 11.43% on the day of the release. Over the subsequent five days, it saw a -8.4% change. Historically, CMPS's stock price tends to shift by an average of 3.25% in the 10 days leading up to earnings and -4.06% in the 10 days following, providing insight into potential market.

For , analysts estimate CMPS's annual revenue to reach undefined, while the EPS is projected at -0.40. These estimates reflect recent revisions, with revenue estimates revised upward by 44.03% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CMPS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised upward by 44.03%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CMPS's stock price typically moves by 3.25% in the 10 days before its earnings and -4.06% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.40 and revenue of undefined.

The company's earnings call highlights significant progress in clinical trials and commercialization plans for COMP360, with positive FDA interactions and accelerated timelines. The Q&A section reveals strong management confidence, despite some vague responses. The absence of a specialty pharma partner and early-stage distribution planning are minor concerns, but overall, the strong clinical results and commercial preparations suggest a positive stock price movement.